Raphas Co., Ltd. (KOSDAQ:214260)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Manufacturing and Sales of Biodegradable Microneedles	30.99B	27.22B	27.94B	23.64B	20.34B
Total	30.99B	27.22B	27.94B	23.64B	20.34B

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
United States of America	2.21B	4.26B	2.80B	3.44B	4.06B
Republic of Korea	22.25B	16.39B	18.92B	15.28B	7.55B
Japan	4.20B	5.66B	5.56B	3.66B	6.31B
Other	2.33B	904.45M	647.77M	1.27B	2.42B
Total	30.99B	27.22B	27.94B	23.64B	20.34B

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error